Biotechnology & Life Sciences

Stock Code

CZD

Stock Exchange

ax

Calzada (CZD), earlier known as Metabolic Pharmaceuticals Limited (MBP), is a Melbourne-based, ASX-listed biotechnology company. Currently, the company is focussing on the development of innovative medical devices following the acquisition of PolyNovo Biomaterials Pty Ltd in December 2008. Where necessary, the company outsources to get expertise for the continued development of its legacy products. Investors can trade Calzada shares on the Australian Stock Exchange (ASX).

Stock Code

CDY

Stock Exchange

ax

Cellmid (CDY) is an Australian biotechnology company committed to contribute to improved patient outcomes by developing a range of therapeutic, prognostic and diagnostic products around midkine. The Company’s disease targets include inflammatory and autoimmune conditions and cancer. The company was listed on Australian Stock Market on 9 December, 2005. Investors can trade Cellmid shares on the Australian Stock Exchange (ASX).

Stock Code

CBZ

Stock Exchange

ax

CBio (CBZ) is an Australian company with a global focus. With a vision to improve patient lives, CBio is focused on developing new generation products for the treatment of autoimmune and inflammatory diseases. The company was listed on Australian Stock Market on 15 February, 2010. Investors can trade CBio shares on the Australian Stock Exchange (ASX).

Stock Code

AVH

Stock Exchange

ax

Avita Medical (AVH) is involved in the development and production of skin regeneration products. The company has four core products: CELLSPRAY, a suspension of autologous cultured epithelial cells that can be sprayed on to the wound surface; CELLSPRAY EXPRESS, a version of CellSpray that can be generated within 48 hours; RECELL, an off-the-shelf kit for harvesting a patient's skin cells; and CELLREPAIR, a biological wound dressing, used in the treatment of chronic wounds. Investors can trade Avita Medical shares on the Australian Stock Exchange (ASX).

Stock Code

APH

Stock Exchange

ax

Ascent Pharmahealth (APH) is a specialist generic pharmaceutical company committed to the development, marketing and distribution of generic pharmaceuticals. APH is also focused on developing new Asian joint venture opportunities to explore broader markets for its products. Investors can trade Ascent Pharmahealth shares on the Australian Stock Exchange (ASX).

Stock Code

AKW

Stock Exchange

ax

Arturus Capital (AKW) is a Sydney-based company involved in the development and commercialisation of haemotology products. Its technologies are focused on developing more cost effective and efficient ways of separating molecules such as proteins from biological fluids.

Stock Code

ADO

Stock Exchange

ax

Anteo Diagnostics (ADO) formerly Biolayer Corporation (BLS) is a materials science company. It provides material science based solutions that change the way immunoassays (clinical disease tests) are developed. BLS focuses on developing novel, high-value, biomimetic polymers for the rapidly growing markets of research and clinical diagnostics immunoassays, bioseparations, drug delivery and medical devices. ADO was listed on the Australian stock market in 7 April, 2000. Investors can trade Anteo Diagnostics shares on the Australian Stock Exchange (ASX).

Stock Code

SIE

Stock Exchange

ax

SciGen (SIE) is a biopharmaceutical company involved in commercialising later stage research. It co-develops and markets vaccines and therapeutics for human healthcare. SciGen’s portfolio includes proprietary products, and biogeneric products, which allow for faster entry into the market. SciGen is a Singaporean biotechnology company, established in 1988 and listed on the Australian Stock Exchange (ASX).

Stock Code

XCD

Stock Exchange

ax

Xceed Capital (XCD) is biotechnology investment company focusing on investments in revenue-producing and research based, leading-edge patentable technologies. The company will initially focus on the development and commercialisation of novel biodegradable polymers; and increasing sales of its and its collaborative partners' products range. The company was listed on the Australian stock market (ASX) in March 1996. Its head office is situated at Monash University, Melbourne. The company was renamed to Xceel Capital Limited in December 2007.

Stock Code

VSC

Stock Exchange

ax

Vita Life Sciences (VSC) is a successful Australian owned pharmaceutical and healthcare company servicing clients throughout Asia and Australia. The company is listed on the Australian Securities Exchange (ASX) on 23 August, 2007.